Public Comment Guidelines

Draft guidelines for the American Society of Hematology (ASH) are made available for public comment here before society approval and publication. Typically, draft recommendations and draft evidence-to-decision frameworks are made available, but not full guideline reports.

Anyone is welcome to comment, including ASH members, non-member physicians and researchers, allied professionals, representatives of industry and insurance companies, patients, caregivers, and members of the public.

ASH Seeks Public Comment on Draft Recommendations for New Guidelines on Treatment of Iron Deficiency With and Without Anemia.

ASH is now accepting public comments on draft recommendations on Treatment of Iron Deficiency With and Without Anemia. Comments will be accepted until November 5, 2026. We encourage all interested healthcare professionals, stakeholder organizations, and individuals to share their feedback on these draft recommendations. All comments will be reviewed by the guideline panel before the guidelines are finalized.

Treatment of Iron Deficiency With and Without Anemia Draft Recommendations

Process for Consideration of Comments Received

All comments received during the open comment period will be provided to the guideline panel for review prior to finalizing the guidelines for publication. Guideline panels are obligated to consider all comments received. Infrequently, ASH guideline panels may change judgments or decisions because of comments. More commonly, panels may provide additional explanations within the final guideline report to explain judgments or decisions. Comments may also inform ASH’s communication and implementation plan for the guidelines, as well as future updates or revisions of the guidelines. ASH will not typically provide individualized responses to comments. Individuals and organizations that provide comments will not typically be identified by name within the final published guidelines. Learn more about ASH's clinical practice guidelines.

Questions?

Please contact guidelines@hematology.org with inquiries related to the public comment period.